Breaking News, Collaborations & Alliances

Frontida BioPharma Completes Facility Expansion

Supports existing product development and manufacturing capabilities.

By: Contract Pharma

Contract Pharma Staff

Frontida BioPharm Inc. has completed a facility expansion to its oral solid dose manufacturing operations with the commissioning of a Highly Potent Compound Contract Manufacturing Suite. This addition features 1000 sq. ft of readily available, hazard-certified production space. Key service equipment and set-ups include a large-scale Roller Compactor, Milling Room, Bin Blender, Tablet Press, and ingress and egress airlocks with enhanced personnel controls. Frontida will utilize these capabilitie...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters